Ariad (NASDAQ: ARIA)

Company Profile

ARIAD Pharmaceuticals is an integrated global oncology company focused on transforming the lives of cancer patients with breakthrough medicines. ARIAD is working on new medicines to advance the treatment of various forms of chronic and acute leukemia, lung cancer and other difficult-to-treat cancers.

Company Info

  • HQ: Boston, USA
Founders and CEO:
  • Harvey Berger
Index Team:
Website:
ariad.com
Sector:
Healthcare
Status:
Exited